Lineage Cell Therapeutics, Inc. (LCTX) quarterly cash flow statement — complete operating, investing & financing history
Lineage Cell Therapeutics, Inc. (LCTX) cash flow statement — 30-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -7.24M | -8.08M | -4.88M | -3.62M | -5.54M | -4.89M | -6.35M | -5.79M | -5.18M | -5.78M | -6.02M | -5.04M | -6.27M | -11.24M | -8.3M | -5.48M | -7.06M | 21.9M | -5.87M | -4.85M |
| Operating CF Margin % | -677.64% | -468.29% | -73.82% | -98.23% | -200.33% | -325.3% | -221.27% | -153.14% | -367.61% | -400.48% | -288.27% | -404.25% | -194.36% | -471.17% | -433.58% | -182.79% | -155.11% | 418.25% | -611.77% | -220.16% |
| Operating CF Growth % | -30.78% | -65.33% | 23.13% | 37.52% | -7.01% | 15.51% | -5.43% | -14.89% | 17.42% | 48.56% | 27.51% | 8.08% | 11.24% | -151.32% | -41.38% | -13.04% | -30.39% | 395.04% | -4.11% | -0.02% |
| Net Income | 1.48M | -4.81M | 951K | -29.75M | -30.36M | -4.14M | -3.27M | -3.03M | -5.76M | -6.56M | -4.78M | -7.16M | -5.2M | -4.4M | -6.36M | -6.07M | -6.78M | -7.09M | -29.19M | -7.84M |
| Depreciation & Amortization | 187K | 188K | 186K | 178K | 171K | 164K | 151K | 141K | 142K | 175K | 175K | 176K | 170K | 171K | 173K | 178K | 179K | 178K | 191K | 199K |
| Stock-Based Compensation | 1.6M | 1.17M | 1.1M | 1.2M | 1.24M | 1.22M | 1.31M | 1.33M | 1.27M | 1.16M | 1.06M | 1.27M | 1.28M | 1.03M | 959K | 0 | 1.24M | 1.11M | 918K | 1.14M |
| Deferred Taxes | 0 | 0 | -5.28M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -554K | 941K | 696K | -1.8M | 0 | 0 | 0 | 0 | 1.18M | -1.01M |
| Other Non-Cash Items | -12.63M | -2.51M | -1.92M | 26.33M | 25.77M | -1.86M | -1.52M | -6.26M | 281K | 366K | -698K | -131K | -190K | 99K | -242K | 1.32M | 2.96M | 589K | -259K | 2M |
| Working Capital Changes | 2.12M | -2.12M | 83K | -1.57M | -2.35M | -268K | -3.02M | 2.04M | -1.11M | -929K | -1.23M | -134K | -3.02M | -6.34M | -2.83M | -911K | -4.66M | 27.12M | 21.29M | 656K |
| Change in Receivables | 19K | 154K | -827K | 130K | -43K | 424K | -233K | -329K | -160K | 668K | -305K | 6K | -242K | 95K | 108K | 95K | -210K | 50.32M | -753K | 249K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -485K | 478K | 0 | 0 | 0 | 325K | 0 | 0 | 0 |
| Change in Payables | -341K | -1.71M | 2.46M | 0 | -354K | 0 | 97K | -1.2M | -671K | -574K | 1.16M | 485K | -478K | -3.46M | 0 | 1.66M | -325K | 0 | 21.29M | 1.31M |
| Cash from Investing | 3.96M | -2.33M | -15.33M | -12K | -14K | 1.9M | 2.63M | 3.89M | -8.79M | -38K | 9.74M | 2.12M | 19.16M | 15.43M | -5.1M | -40.91M | -97K | -46K | -146K | -68K |
| Capital Expenditures | 55K | -55K | -111K | -12K | -14K | -97K | -365K | 88K | -50K | -38K | -91K | -139K | -256K | -188K | 16K | -286K | -97K | -46K | -146K | -68K |
| CapEx % of Revenue | 5.15% | 3.19% | 1.68% | 0.33% | 0.51% | 6.46% | 12.73% | 2.33% | 3.55% | 2.63% | 4.36% | 11.16% | 7.94% | 7.88% | 0.84% | 9.54% | 2.13% | 0.88% | 15.21% | 3.09% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.26M | -19.41M | 188K | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -163K | 0 | -288K | 0 | 0 | 0 | 0 | -200K | 0 | 0 | 0 | 2.26M | 19.41M | -188K | 7.67M | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 4.47M | 5.56M | 20.38M | 1.83M | -307K | 5.04M | 21.73M | -3K | 105K | 14.02M | -13K | 807K | 5.63M | 1K | 122K | 964K | 33K | 513K | 954K | 3.72M |
| Debt Issued (Net) | 0 | -14K | -15K | -16K | -14K | -14K | -14K | -13K | -14K | -13K | -13K | -12K | -16K | -13K | -9K | -8K | -7K | -8K | -7K | -13K |
| Equity Issued (Net) | 0 | 5.62M | 20.39M | 2.08M | -65K | 5.28M | 21.81M | 10K | 33K | 13.9M | -199K | 836K | 5.79M | -37K | 0 | 972K | -9K | 140K | 111K | 2.91M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | -15K | 0 | 0 | 0 | -23K | -199K | 0 | 0 | -37K | 0 | 0 | -9K | -8K | -13K | -14K |
| Other Financing | 4.47M | -40K | -1K | -232K | -228K | -224K | -58K | -3K | 86K | 132K | 199K | -17K | -145K | 51K | 131K | 0 | 49K | 381K | 850K | 818K |
| Net Change in Cash | 1.98M | -4.85M | 347K | -1.8M | -5.57M | 1.99M | 18.05M | -1.86M | -13.95M | 8.13M | 3.99M | -2.45M | 18.43M | 4.08M | -13.36M | -45.56M | -7.25M | 22.33M | -5.05M | -1.19M |
| Free Cash Flow | -7.19M | -8.13M | -4.99M | -3.63M | -5.55M | -4.98M | -6.71M | -5.7M | -5.23M | -5.82M | -6.11M | -5.18M | -6.52M | -11.43M | -8.29M | -5.77M | -7.16M | 21.86M | -6.02M | -4.92M |
| FCF Margin % | -672.5% | -471.48% | -75.5% | -98.56% | -200.83% | -331.76% | -234% | -150.81% | -371.16% | -403.12% | -292.62% | -415.41% | -202.29% | -479.04% | -432.74% | -192.33% | -157.24% | 417.38% | -626.98% | -223.25% |
| FCF Growth % | -29.46% | -63.21% | 25.66% | 36.34% | -6.26% | 14.4% | -9.84% | -10.1% | 19.9% | 49.07% | 26.27% | 10.23% | 8.87% | -152.29% | -37.68% | -17.29% | -29.11% | 393.99% | -6.25% | -0.92% |
| FCF per Share | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 | -0.03 | -0.03 | -0.03 | -0.04 | -0.03 | -0.04 | -0.07 | -0.05 | -0.03 | -0.04 | 0.13 | -0.04 | -0.03 |
| FCF Conversion (FCF/Net Income) | -4.89x | 1.68x | -5.73x | 0.12x | 0.18x | 1.18x | 1.94x | 1.91x | 0.90x | 0.88x | 1.26x | 0.71x | 1.20x | 2.57x | 1.31x | 0.90x | 1.04x | -3.09x | 0.20x | 0.62x |
| Interest Paid | 0 | 0 | 0 | -50K | 9K | 14K | 3K | 0 | 0 | 2K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5K | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |